Therapy News and Research

RSS

$Optimizing guideline-directed medical therapy for heart failure with reduced ejection fraction$

Optimizing guideline-directed medical therapy for heart failure with reduced ejection fraction

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Over the past several decades, major strides have been made in the management of heart failure with reduced ejection fraction (HFrEF).

5 Dec 2023

Study uses game theory to show low tumor heterogeneity leads to higher aggression

A study by the University of the Basque Country (UPV/EHU) uses game theory to establish that tumors with less cellular heterogeneity are more aggressive.

5 Dec 2023

Investigating IDO1 and PDL1: Key immune checkpoints in cutaneous leishmaniasis research

In this Interview News Med talks to Dr. Nidhi Dey about immune checkpoints IDO1 and PDL1 and how they relate to cutaneous leishmaniasis research.

From TissueGnostics 5 Dec 2023

Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson's Disease, recent trial suggests

A safe and feasible treatment option for reducing the motor signs of Parkinson's disease.

5 Dec 2023

Can ketogenic diet offer an effective alternative to antiseizure medication in infants with drug-resistant epilepsy?

The effectiveness of ketogenic diets in lowering seizure frequency among newborns.

5 Dec 2023

Brown seaweed emerges as a potent ally in diabetes control

A study in the journal Nutrients found that brown seaweed consumption (BSC) effectively manages type 2 diabetes (T2D) risk and regulates blood glucose levels in patients.

4 Dec 2023

Study offers new insights into ketamine's rewiring of the brain

Ketamine – an anesthetic also known for its illicit use as a recreational drug – has undergone a thorough reputational rehabilitation in recent years as the medical establishment has begun to recognize its wide-ranging therapeutic effects.

4 Dec 2023

New discovery unveils an additional layer of the CRISPR-Cas antiviral defense system

The recent publication in Science by Mogila, Tamulaitiene et al. represents a continuation of the successful scientific research conducted by Gintautas Tamulaitis' group.

4 Dec 2023

UCLA studies unravel metabolic pathways in prostate cancer treatment

Two new studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center give insight into how cells use energy to influence the way prostate tumors survive and grow - advancements that can help explain why some prostate cancers become resistant to hormone therapy, the most commonly used treatment for men with advanced stages of the disease.

4 Dec 2023

Shining a light on thalassemia: Global report unveils knowledge gaps and opportunities

Thalassemia, a hereditary hemoglobinopathy, occurs in 4.4 out of every 10,000 live births and is prevalent in Mediterranean coastal areas, Africa, the Middle East, Southeast Asia, and southern China.

4 Dec 2023

Does tinnitus cause hearing loss in normal hearing individuals?

Whether cochlear neural degeneration occurs in normal-hearing individuals with tinnitus.

4 Dec 2023

Navigating STXBP1-related disorders: Unraveling clinical and developmental outcomes

Researchers examined the combined patient-years of seizure and developmental histories in individuals with disorders related to the STXBP1 gene.

4 Dec 2023

New program launched to accelerate access to personalized therapies for children with rare conditions

Today, Wednesday 22 November, the government announced its support for the Rare Therapies Launch Pad, a new programme that will develop a pathway for children with rare conditions to access individualized therapies.

4 Dec 2023

Innovative, wearable device can significantly improve postural control

Scientists develop an innovative device to help older individuals train their posture control, minimizing the risk of falls and associated injuries.

4 Dec 2023

Texas Children's Hospital delivers first-ever gene therapy for Rett syndrome

Texas Children's Hospital, an internationally-recognized, top-ranked children's hospital and pediatric research center affiliated with Baylor College of Medicine, is the first to deliver a novel gene therapy to treat Rett syndrome in pediatric patients.

1 Dec 2023

CHOP researchers unlock 3D structure of crucial protein for cancer therapy

Chimeric Antigen Receptors (CARs) have opened up an exciting new field of therapeutic advancements for rare and difficult-to-treat cancers, as they have the ability to deliver targeted therapies that can kill tumor cells.

1 Dec 2023

Study finds racial disparity in the utilization of crucial prostate cancer therapy

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found Black men diagnosed with more advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy than other racial and ethnic groups – including white or Latino men – despite the therapy being proven to effectively control the growth of prostate tumors and extend the lives of men with the disease.

1 Dec 2023

Combining AI, ctDNA, and histopathology for improved treatment stratification in colorectal cancer

Combining artificial intelligence-generated digital pathology tools, conventional histopathological assessment and circulating tumor DNA (ctDNA) analysis can improve treatment stratification of patients with colorectal cancer after surgery.

1 Dec 2023

ADA Forsyth scientists test novel technology to treat endodontic diseases more effectively

Want to avoid a root canal? In the future, you might be able to opt for tissue regeneration instead. ADA Forsyth scientists are testing a novel technology to treat endodontic diseases (diseases of the soft tissue or pulp in your teeth) more effectively.

1 Dec 2023

New drug combination may improve treatment for rare nerve sheath tumors

Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies led by investigators at the Johns Hopkins Kimmel Cancer Center and Johns Hopkins Drug Discovery.

1 Dec 2023

Therapy News and Research

Optimizing guideline-directed medical therapy for heart failure with reduced ejection fraction

Study uses game theory to show low tumor heterogeneity leads to higher aggression

Investigating IDO1 and PDL1: Key immune checkpoints in cutaneous leishmaniasis research

Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson's Disease, recent trial suggests

Can ketogenic diet offer an effective alternative to antiseizure medication in infants with drug-resistant epilepsy?

Brown seaweed emerges as a potent ally in diabetes control

Study offers new insights into ketamine's rewiring of the brain

New discovery unveils an additional layer of the CRISPR-Cas antiviral defense system

UCLA studies unravel metabolic pathways in prostate cancer treatment

Shining a light on thalassemia: Global report unveils knowledge gaps and opportunities

Does tinnitus cause hearing loss in normal hearing individuals?

Navigating STXBP1-related disorders: Unraveling clinical and developmental outcomes

New program launched to accelerate access to personalized therapies for children with rare conditions

Innovative, wearable device can significantly improve postural control

Texas Children's Hospital delivers first-ever gene therapy for Rett syndrome

CHOP researchers unlock 3D structure of crucial protein for cancer therapy

Study finds racial disparity in the utilization of crucial prostate cancer therapy

Combining AI, ctDNA, and histopathology for improved treatment stratification in colorectal cancer

ADA Forsyth scientists test novel technology to treat endodontic diseases more effectively

New drug combination may improve treatment for rare nerve sheath tumors

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News